ES2527504T3 - Método antivírico - Google Patents

Método antivírico Download PDF

Info

Publication number
ES2527504T3
ES2527504T3 ES11174632.7T ES11174632T ES2527504T3 ES 2527504 T3 ES2527504 T3 ES 2527504T3 ES 11174632 T ES11174632 T ES 11174632T ES 2527504 T3 ES2527504 T3 ES 2527504T3
Authority
ES
Spain
Prior art keywords
policuaternio
polyquaternium
composition
alcoholic composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES11174632.7T
Other languages
English (en)
Spanish (es)
Inventor
Marcia Snyder
David R. Macinga
James W. Arbogast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Go-Jo Industries Inc
Original Assignee
Go-Jo Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/499,227 external-priority patent/US8119115B2/en
Priority claimed from US11/670,114 external-priority patent/US20070185216A1/en
Application filed by Go-Jo Industries Inc filed Critical Go-Jo Industries Inc
Application granted granted Critical
Publication of ES2527504T3 publication Critical patent/ES2527504T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES11174632.7T 2006-02-09 2007-02-07 Método antivírico Active ES2527504T3 (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US670114 1991-03-15
US77174406P 2006-02-09 2006-02-09
US771744P 2006-02-09
US499227 2006-08-07
US11/499,227 US8119115B2 (en) 2006-02-09 2006-08-07 Antiviral method
US11/670,114 US20070185216A1 (en) 2006-02-09 2007-02-01 Antiviral method

Publications (1)

Publication Number Publication Date
ES2527504T3 true ES2527504T3 (es) 2015-01-26

Family

ID=47110757

Family Applications (1)

Application Number Title Priority Date Filing Date
ES11174632.7T Active ES2527504T3 (es) 2006-02-09 2007-02-07 Método antivírico

Country Status (7)

Country Link
KR (1) KR101319151B1 (enExample)
CN (1) CN102973540B (enExample)
DK (1) DK2471559T3 (enExample)
ES (1) ES2527504T3 (enExample)
IN (1) IN2014DN07845A (enExample)
MY (1) MY148678A (enExample)
PT (1) PT2471559E (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410510D0 (en) * 2014-06-12 2014-07-30 Fantex Ltd Liquid Antimicrobial
KR102200507B1 (ko) 2019-12-11 2021-01-08 주식회사 아워홈 바이러스 소독용 조성물
CN111513067A (zh) * 2020-04-29 2020-08-11 江苏斯微特医药科技有限公司 复合醇氧糖消毒液
WO2022038955A1 (ja) * 2020-08-20 2022-02-24 大日本除蟲菊株式会社 ウイルス不活性化剤組成物およびウイルス不活性化効力増強方法、並びにウイルス不活性化方法
KR20220030428A (ko) 2020-08-31 2022-03-11 주식회사 원우정밀 미세 스프레이 분사 방식의 살균 소독 장치
US20220135904A1 (en) * 2020-11-02 2022-05-05 Microban Products Company Use of ethoxylated alcohols to impede enveloped viral spread
CN118620201B (zh) * 2024-01-30 2025-03-14 江苏斯德瑞克化工有限公司 一种连续化制备聚噻氯铵的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3702983A1 (de) * 1986-06-09 1987-12-10 Henkel Kgaa Desinfektionsmittel und ihre verwendung zur haut- und schleimhautdesinfektion
JP2004529889A (ja) * 2001-02-28 2004-09-30 コノワルチュク，トーマス・ダブリュ 殺ウイルス性組成物

Also Published As

Publication number Publication date
DK2471559T3 (en) 2015-01-12
KR101319151B1 (ko) 2013-10-17
HK1129608A1 (en) 2009-12-04
PT2471559E (pt) 2014-12-09
CN102973540B (zh) 2015-08-19
IN2014DN07845A (enExample) 2015-07-10
HK1183623A1 (en) 2014-01-03
MY148678A (en) 2013-05-31
CN102973540A (zh) 2013-03-20
KR20120102141A (ko) 2012-09-17

Similar Documents

Publication Publication Date Title
ES2527504T3 (es) Método antivírico
UY30481A1 (es) Isoxazolinas sustituidas, composiciones farmaccuticas que contienen a las mismas, metodos de preparacion y usos.
ES2526555T3 (es) Composición fungicida y método para controlar enfermedades de plantas
CL2009002207A1 (es) Compuestos derivados de 3-hidroxi-5-(9h-purin-9-il)tetrahidrofuran-2-il, inhibidor de la replicacion de arn viral dependiente de arn; composicion farmaceutica; uso para el tratamiento de hepatitis c.
CY1119269T1 (el) Θεραπεια βλαβων που προκαλουνται απο ιους
UY32503A (es) Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector
AR072072A1 (es) Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669
CR9230A (es) Uso de derivados del acido tetramico para el control de los insectos del genero de los hemipteros (sternorrhyncha)
CR20170563A (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso.
EA202091999A3 (ru) Применение ингибиторов dpp iv
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
PE20090938A1 (es) Composicion farmaceutica que comprende un derivado de benceno sustituido con glucopiranosilo
CR9722A (es) Derivados de benzilpiperazina y su uso medico
CL2008000445A1 (es) Metodo para la profilaxis y el tratamiento de una infeccion subclinica por circovirus porcino tipo 2 (pcv2) en un animal individual o un grupo de animales que comprende administrar un antigeno del pcv2; uso del antigeno pcv2 para la profilaxis de un
NI201200189A (es) "composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona"
CL2007003065A1 (es) Compuestos derivados de benzodioxano, agonista 5ht2c, composicion farmaceutica que lois comprende; y sus uso en el tratamiento de un trastorno psicotico, ansiedad, depresion, trastorno bipolar, sindrome premenstrual, entre otros
AR077125A1 (es) Combinaciones farmaceuticas utiles para tratar el vhc
ECSP088689A (es) NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS
UY29639A1 (es) Amidas sustituidas con heteroarilo que comprenden un grupo enlazador insaturado o cíclico, y su uso como productos farmacéuticos
ES2452034T5 (es) Composición para el cuidado de prótesis dental
PE20091032A1 (es) Composicion que contiene n-(3-metoxi-5-metilpirazin-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridin-3-sulfonamida (zibotentan)
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.
CL2009002036A1 (es) Uso de una composicion que comprende 100% en peso de trans-clomifeno, como ingrediente activo, sales o solvatos del mismo para preparar un medicamento util para prevenir o tratar la diabetes mellitus tipo 2 en un sujeto de sexo masculino.
ES2660019T3 (es) Parche que contiene diclofenaco y tiocolchicósido
CO6321223A2 (es) Formulacion farmaceutica solida que contiene ciclostazol